Skip to main content
Menu
Why A COVID-19 Vaccine Trial Would Press Pause

On this week’s episode of PODCAST-19, we discuss the news that AstraZeneca’s COVID-19 vaccine trial has been paused because of a severe side effect for one participant, and how temporarily halting a trial can sometimes mean the process is working as intended.

Don’t want to miss an episode of PODCAST-19, FiveThirtyEight’s weekly look at what we know — and what we know we don’t know — about COVID-19? Subscribe on your favorite podcasting app. For example, here’s where to do it on Apple Podcasts and Spotify.

Anna Rothschild is FiveThirtyEight’s senior producer for video.

Sinduja Srinivasan is PODCAST-19’s producer.

Comments